title: Management of subglottic hemangioma with propranolol.
abstract: Subglottic hemangioma is a rare but life- threatening condition which requires intervention. It generally starts proliferating in the first and second months of lifespan and whether there is a respiration problem or not, it causes biphasic stridor. Its diagnosis generally requires direct laryngoscopy or direct screening through bronchoscopy. This case report presents a 45-day-old girl who had subglottic hemangioma presenting with wheezing and stridor. Our case took propranolol with a dose of 2 mg/kg/day and within 48 h after the start of the treatment, obstructive symptoms started to alleviate considerably.
authors.affiliation: Department of Pediatric Allergy and Immunology, Ondokuz Mayıs University Medical Faculty, Samsun, Turkey. Electronic address: drmhc@hotmail.com.
authors.forename: Mehmet Halil
authors.initials: MH
authors.lastname: Celiksoy
authors.affiliation: Department of Pediatric Intensive Care, Ondokuz Mayıs University Medical Faculty, Samsun, Turkey.
authors.forename: Muhammet Sukru
authors.initials: MS
authors.lastname: Paksu
authors.affiliation: Department of Otolaryngology, Ondokuz Mayıs University Medical Faculty, Samsun, Turkey.
authors.forename: Sinan
authors.initials: S
authors.lastname: Atmaca
authors.affiliation: Department of Pediatric Allergy and Immunology, Ondokuz Mayıs University Medical Faculty, Samsun, Turkey.
authors.forename: Recep
authors.initials: R
authors.lastname: Sancak
authors.affiliation: Department of Pediatrics, Ondokuz Mayıs University Medical Faculty, Samsun, Turkey.
authors.forename: Gonca
authors.initials: G
authors.lastname: Hancioglu
mesh_terms: D005260:Female; D006391:Hemangioma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007223:Infant; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D012135:Respiratory Sounds / Q000503:physiopathology; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D011433:Propranolol